Role of Immunotherapy in the Treatment of Squamous Cell Carcinoma of the Anal Canal.
This article reviews the early successes of anti-PD-1 therapies and adoptive T-cell therapies for metastatic anal cancer as a potential foundation for novel combination immunotherapy trials in the future.
PMID: 30006430 [PubMed - in process]
Source: Journal of the National Comprehensive Cancer Network : JNCCN - Category: Cancer & Oncology Tags: J Natl Compr Canc Netw Source Type: research
More News: Anal Cancer | Cancer | Cancer & Oncology | Carcinoma | Genital Warts | Human Papillomavirus (HPV) | Immunotherapy | Skin Cancer | Squamous Cell Carcinoma